Avid Bioservices Inc (CDMO)

[bfiest]

A reverse split at this juncture would be more than irresponsible without news ensuring value is maintained or increased -- that is unless Bavi proves to have no worth. They have the ability and seem to be structuring things properly with their focus on increasing revenues with avid and mitigating their costs through the arrangement they have with AZN while also focusing on gaining synergies with MSK and NCCN likely with AZN directing the entire process ensuring maximum efficiency and structure. If this is truly the plan and if this is managed properly, the only thing that should derail this effort is if Bavi doesn't show efficacy. Obviously we don't really know what is happening behind the scenes which is cause for concern but it appears to be a positive and logical plan. I am comfortable with this management group focusing on avid because they seem to have managed that process well to date. I think, I hope from a clinical standpoint the ball is completely in AZN's hands now. It appears to be more so every day. It all comes down to Bavi showing efficacy or not. As an investor, personally, I am good with that. But I still need more evidence that things are proceeding responsibly. All in my opinion.